Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
CA 2289124 A1 · Owner: Schmitz, Tracy · Inventors: Huber, Brigitte T.; Schmitz, Tracy; Underwood, Robert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of a molecule that inhibits CD26 for the preparation of a medicament for increasing the immune response of a human patient infected with HIV by , contacting the T-cells, in vitro or in vivo with the said molecule at a , concentration effective to cause T-cell proliferation but below an amount , that causes detectable cytotoxicity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 30, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.